This announcement is a separate document:
赛隆药业:第四届董事会独立董事专门会议2024年第二次会议的审查意见
Sailong Pharmaceutical: Review Opinions of the 2nd Meeting of the 4th Special Meeting of Independent Directors of the Board of Directors in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.